Beyond Air (XAIR) Cash from Financing Activities (2016 - 2026)
Beyond Air (XAIR) reported Cash from Financing Activities of $4.9 million for Q1 2026, up 8.91% on a YoY basis from $4.5 million in Q1 2025, and up 2350.5% sequentially from $200000.0 in Q4 2025.
Beyond Air (XAIR) Cash from Financing Activities (2016 - 2026) Analysis & Trends
Beyond Air (XAIR) has 11 years of Cash from Financing Activities data on file, last reported at $4.9 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 8.91% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $18.1 million (up 8.64% YoY), and the FY2026 full-year result was $29.1 million, up 74.76% from the prior year.
- Cash from Financing Activities climbed to $4.9 million in Q1 2026, from $200000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $21.6 million in Q3 2024 to a low of -$9.2 million in Q4 2024.
- A 5-year average of $5.1 million and a median of $4.1 million in 2025 frame the typical range for Cash from Financing Activities.
- Peak annual rise in Cash from Financing Activities reached 4510.66% in 2024, while the deepest fall reached 275.91% in 2024.
- Tracing XAIR's Cash from Financing Activities over 5 years: stood at -$310000.0 in 2022, then soared by 1789.68% to $5.2 million in 2023, then tumbled by 275.91% to -$9.2 million in 2024, then surged by 102.17% to $200000.0 in 2025, then jumped by 2350.5% to $4.9 million in 2026.
- Business Quant data shows XAIR's Cash from Financing Activities at $4.9 million in Q1 2026, $200000.0 in Q4 2025, and $8.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Beyond Air | 2.25 Mn | -10.02 Mn | 94,000.00 | 4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.90 Mn |
| Mar 31, 2026 | 4.90 Mn |
| Dec 31, 2025 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 8.92 Mn |
| Sep 30, 2025 | 8.92 Mn |
| Jun 30, 2025 | 4.07 Mn |
| Jun 30, 2025 | 4.07 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Mar 31, 2025 | 4.50 Mn |
| Dec 31, 2024 | -9.21 Mn |
| Dec 31, 2024 | -9.21 Mn |
| Sep 30, 2024 | 21.62 Mn |
| Sep 30, 2024 | 21.62 Mn |
| Jun 30, 2024 | -264,000.00 |
| Jun 30, 2024 | -264,000.00 |
| Mar 31, 2024 | 15.89 Mn |
| Mar 31, 2024 | 15.89 Mn |
| Dec 31, 2023 | 5.24 Mn |
| Dec 31, 2023 | 5.24 Mn |